MEMBER LOG-IN

LOGIN HELP

LogIn Help

SIGN UP

CLICK TO CREATE AN ACCOUNT
JOIN US or FOLLOW US HERE go to linkedIn go to twitter

New Account Registration

Yes No

Please sign me up for these other regions too:

JPMorgan BioBreak
Europe BioBreak
Philly BioBreak
New Jersey BioBreak
Boston BioBreak
All Regions
Yes No

Refer a Friend

Reset Password

Boston BioBreak – Events Archive

Please see below for attendees and images from this event.

Boston Boston BioBreak October 26, 2017 5:30-7:30 pm

Attendees at this event

Geoff Meyerson Locust Walk
Peter Lanciano Periphagen Inc.
Jordan Leef Pyramid Biosciences Inc
Jeb Keiper Nimbus Therapeutics
Imran Eba Action Potential Venture Capital
John Ripple Exonics Therapeutics
Jason Walsh Provenance Biopharmaceuticals
Brad Prosek Constellation Pharmaceuticals
Catherine Lenich Beth Israel Deaconess Medical Center
Yukari Perrella Yuma Therapeutics
Kleem Chaudhary Takeda
Paul Conrad Shire
Andre Turenne Sanofi
Douglas MacDougall MacDougall Biomedical Communications
Brad Carver SynDevRx
Rick Lundberg Navitor Pharmaceuticals
Adam Muzikant Flexion Therapeutics
Alan Kugler Coastal Pharma Group
Eric Elenko PureTech Ventures
Jonathan Behr JDRF T1D Fund
Michal Preminger Harvard University
David Brush Johnson & Johnson
Gordon Jamieson Translational Therapeutics
Kathryn Gregory Shire Pharmaceuticals
PJ Anand Alcyone Lifesciences
John Gustofson AbbVie
Barbara Fox Tilos Therapeutics
Eric Olson Shire
Mark Fraga Life Sciences
Lloyd Dahmen AstraZeneca
Steven Tregay FORMA Therapeutics
Jeff Imbaro Semma Therapeutics
Arthur Hiller Antyllus Therapeutics
Scott Edwards SciFluor Life Sciences
Markus Haeberlein Alkermes
Tom Andrews Alexandria Real Estate Equities
Sunny Saxena Revelation Partners
Grant Zimmermann Harvard University
Andy Meyerson Locust Walk
Gill Fishman Gill Fishman Associates/Design
Brendan Downey Takeda
Michael Boretti Epizyme
Kees Been Lysosomal Therapeutics
Ryan Dietz Boston Children's Hospital
Elizabeth Reczek SeqLL, LLC
John Tagliamonte WntRx
Debra Peattie GlaxoSmithKline
John Delyani Merck
Tariq Kassum Obsidian
Chuck Kunsch AbbVie Ventures
James Shanahan SynDevRx, Inc.
Alexander Pickett Mediqventures, Ltd.
Jennifer King Intellia Therapeutics
Rich Howlett Keros Therapeutics
Bob Palladino Bionevia LLC
Josh Hamermesh Locust Walk
James Gorman Startup Mode
Lizabeth Leveille Merck
John Flatley The Flatley Foundation
Tom Anderson Sage Therapeutics
David Standring
Walter Olesiak Remiges Ventures
Brian Hess LaunchPad Medical
Bernard Davitian Sanofi
Mustafa Noor Akcea Therapeutics
Maude Tessier Merck
Laura Brass MPM Capital
Roman Fleck Janpix
Alexander Kraus AK Pharma Consulting
Stephen Potter AGTC
Mark Stencik Merck
Ravi Rao Vtesse
Neal Farber NEUROHEALING PHARMACEUTICALS
Timothy Sullivan AJU IB Investment
Christopher Earl Merck Global Health Innovation Fund
Christo Shalish Warp Drive Bio
Peter Williams ImmunoGen, Inc.
Vicki Morgan viDA Therapeutics
Andrew meadow Excelyrate Capital
Fumitaka Mori Remiges Ventures
Lisa Paborsky Mitobridge
Tarik Soliman Extend Biosciences
Anna Christo MassBio
Joel Batson RA Capital Management
Thomas Martz Goldfinch Bio
Chris Gemmiti Sentien Biotech
Guillermo Rubio AMAG Pharmaceuticals
Ibraheem Badejo J & J Innovation
Jennifer Wheler Novartis
Remis Bistras ProFarma
Christopher Scannell Akrivis
Stephen Curtis Eli Lilly and Company
Christian Cortis Agenus
Christine Brennan MRL Ventures Fund
Daniel Macaya RA capital
Ted Marple Acworth Pharmaceuticals, Inc.
Brian Miller Sentien Biotechnologies, Inc.
David Sherris GenAdam Therapeutics
Glenn Larsen Aquinnah Pharmaceuticals
Chieze Ibeneche-Nnewihe RA Capital
Joel BERNIAC Akrivis Technologies
Laurence Reid Warp Drive Bio
Bruce Beutel SQZ Biotech
Ben Palleiko Cielo Therapeutics
Amanda Kay Synlogic
Sara Nunez-Garcia Sofinnova Partners
Milenko Cicmil Merck
Rodolphe Clerval ENTEROME
Kevin Mills Cyteir Therapeutics, Inc
Samta Kundu Bristol-Myers Squibb
Yury Kukushkin 4biocapital
Jennifer Ma Novartis
Laura Indolfi PanTher Therapeutics
John M Sorvillo ReForm Biologics
Elizabeth Wagner Constant Pharmaceuticals
Eric Furfine ImmuneXcite, Inc.
Patrick Rivelli MIT Angels
Jim Ellis GSK
Matthew Smith Pear Therapeutics
Kevin Pong Summit Therapeutics
Diala Ezzeddine Xios Therapeutics
Alan Ginsberg Shire
Dodzie Sogah Scholar Rock
Morris Birnbaum Pfizer
Jim Winkler Forma
Anthony Walsh RA Capital LLC
Michael McCully Locust Walk
Bill Whelan Mintz Levin
A.J. Kumar Jana Care
Laura Stoppel RA Capital Management
Meg Krench RA Capital Management
Lawrence Klein CRISPR Therapeutics
Adi Mashiach Mesia Ventures
Michael Dudley TransCode Therapeutics, Inc.
Evan Thompson Abcuro
Shawn Marcell ReadCoor
Komal Joshi Jounce Therapeutics
VIPULA TAILOR Azure8
Jeff Stevens Puretech Health
Matthew Schiller EMD Serono
Larry Cai Qilu
Jason Ruth 5AM Ventures
Kathryn McCabe Eli Lilly
Jonathan Freeman Vedanta Biosciences
Omid Akhavan MVM Life Science Partners
Laura Tadvalkar MP Healthcare Venture Management
Kerrie Brady Cetrexion Therapeutics
Sven Riethmueller Pepper Hamilton
Victor Shifrin ImmunoChem Therapeutics
Joep Muijrers LSP Life Sciences Partners
Rajeev Chillakuru Boston Pharmaceuticals
Jin Ji PulchriBio
Thomas Leggett Axcella Health
Mirella Mashiach Mesia Ventures
Reza Mazhari Novartis Institutes for BioMedical Research
Sophie Chapelle Scipher Medicine
Maria Palasis 480 Biomedical, Inc.
John Dellapa Mintz Levin
Anna French Qiming Venture US
Evan Lippman Takeda Pharmaceuticals
Thurein Htoo Novelion Therapeutics
Rosy Hu Partners Innovation Fund
Lauren Shearman Pfizer
Frank Sanders SAGE Therapeutics
Aileen Healy Pfizer
Isabella Zhang JDRF T1D Fund
Melissa BradfordKlug Keryx
Brian DeSchuytner TESARO
Erika Bechtold Sofregen Medical
TIm Funnell Third Rock Ventures
Alex Nichols Mythic Therapeutics
James Jogerst Opsidio
Adam Buckley VBI Vaccines Inc
Kim Seth Repare Therapeutics
Ravneesh Sachdev Bioverativ
Kathryn McAllister Amgen
Fred Chereau LogicBio
Tom Wilton LogicBio
Devin Quinlan MPM Capital
Matthias Jaffe LogicBio
Seiji Nakano Asahi Kasei - Healthcare
Kyle Dempsey MVM Partners
Dominique Verhelle Third Rock Ventures
Marion Hitchcock Bayer
Marco de Boer NTrans Technolgies
Barbara Hibner PercepTx
Abbas Berdi Chambers Point Capital

Become a Supporter

For more information about sponsorship, please email us at sponsorship@biobreak.org.

Web design: GillFishmanDesign.com